-
Survivor Profile
Breaking Down BarriersCancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.
by Bradley Jones
-
Forward Look
Going FlatMost people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
-
Forward Look
First CAR-T Cell Therapy Approved for Multiple MyelomaCellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
-
Q&A
Cancer, From the Other SideWhen Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.
by Marci A. Landsmann
-
Forward Look
The Impact of HPV VaccinationOver a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.
by Carisa D. Brewster
-
Forward Look
Sexual Health in Adolescent and Young Adult SurvivorsCancer survivors diagnosed early in life may have unanswered questions about their sexual health.
by Lindsey Konkel
-
Get Involved
Bringing Joy to the Pediatric WardStudents Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.
by Bradley Jones
-
Forward Look
What’s Next? Summer 2021Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
-
Facts and Stats
Categorizing Skin CancerA knowledge of the different types of skin cancer can help you remain vigilant.
by Bradley Jones
-
A Treatment That Came Just in Time
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin